previous compound ID: 2698 next compound
InChIKey: YGWFCQYETHJKNX-UHFFFAOYSA-N
SMILES: CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "JW Hanrahan" "J Liao" "GW Carlile" "R Robert" "DY Thomas" "B Kus" "E Matthes" "J Goepp" "SD Macknight"

chemical graph of compound 2698





CID is 14634
synonyms found at PubChem are:
Rhinactin, Olynth, Neo-Synephrine II, EINECS 214-936-4, 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline monohydrochloride, UNII-X5S84033NZ, 2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-, MONOHYDROCHLORIDE, 1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-, monohydrochloride, X5S84033NZ, Xylometazoline hydrochloride [USP], Otrivin hydrochloride, 1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-, hydrochloride (1:1), AC1L248X, 526-36-3 (Parent), CX-004, LS-79582, 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazol-1-ium chloride, 28096-10-8, 8057-34-9, AC1LCW8F, AKOS026749771, 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole; hydron; chloride, Xylometazoline hydrochloride, 1218-35-5, Xylometazoline HCl, 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline hydrochloride, Xylometazoline (hydrochloride), MLS000069695, SMR000058526, DSSTox_CID_25223, DSSTox_RID_80760, DSSTox_GSID_45223, 2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride, 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole hydrochloride, Xylometazoline hydrochloride (USP), SR-01000000230, NCGC00016101-02, CAS-1218-35-5, 2-(4-tert-butyl-2,6-dimethylbenzyl)-4,5-dihydro-1h-imidazole hydrochloride, stas hydrochloride, otrivinhydrochloride, otrivinehydrochloride, Prestwick_574, AC1NQZZM, 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride, 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-, hydrochloride (1:1), Opera_ID_1744, xylometazolin hydrochloride, Neo-Synephrine II (TN), SCHEMBL41837, MLS001076518, SPECTRUM1500614, CHEMBL1256400, DTXSID3045223, CTK4B2768, MolPort-001-768-551, REGID_for_CID_5282386, YGWFCQYETHJKNX-UHFFFAOYSA-N, HMS1568N07, HMS1921K09, Pharmakon1600-01500614, Xylometazoline Hydrochloride ,(S), BCP22148, HY-B0475, Tox21_110305, Tox21_501269, ANW-41892, CCG-39900, MFCD00238707, NSC757378, s2576, AKOS015895456, Tox21_110305_1, AC-8301, AN-8175, API0006284, CS-2589, KS-5144, LP01269, NSC-757378, NCGC00016101-10, NCGC00094506-01, NCGC00094506-02, NCGC00094506-03, NCGC00094506-04, NCGC00094506-05, NCGC00261954-01, H812, AB0013278, AB1009546, KB-223225, TR-003540, EU-0101269, FT-0603554, D00757, K-1647, X 6000, Xylometazoline hydrochloride, analytical standard, 218X355, A804796, I06-0599, J-004686, SR-01000000230-2, SR-01000000230-7, 2-(4-tert-butyl-2,6-dimethylbenzyl)-2-imidazolinmonohydrochloride, Xylometazoline hydrochloride, British Pharmacopoeia (BP) Reference Standard, Xylometazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard, 2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole hydrochloride, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1h-imidazol, Xylometazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard